1. The SARS-CoV-2 Spike Protein Receptor-Binding Domain Expressed in Rice Callus Features a Homogeneous Mix of Complex-Type Glycans.
- Author
-
Sobrino-Mengual G, Armario-Nájera V, Balieu J, Walet-Balieu ML, Saba-Mayoral A, Pelacho AM, Capell T, Christou P, Bardor M, and Lerouge P
- Subjects
- Glycosylation, Humans, Protein Domains, Protein Binding, Plants, Genetically Modified metabolism, COVID-19 virology, COVID-19 metabolism, Spike Glycoprotein, Coronavirus metabolism, Spike Glycoprotein, Coronavirus chemistry, Spike Glycoprotein, Coronavirus genetics, Oryza metabolism, Oryza genetics, Oryza virology, Polysaccharides metabolism, SARS-CoV-2 metabolism
- Abstract
The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is required for the infection of human cells. It is the main target that elicits neutralizing antibodies and also a major component of diagnostic kits. The large demand for this protein has led to the use of plants as a production platform. However, it is necessary to determine the N -glycan structures of an RBD to investigate its efficacy and functionality as a vaccine candidate or diagnostic reagent. Here, we analyzed the N -glycan profile of the RBD produced in rice callus. Of the two potential N -glycan acceptor sites, we found that one was not utilized and the other contained a mixture of complex-type N -glycans. This differs from the heterogeneous mixture of N -glycans found when an RBD is expressed in other hosts, including Nicotiana benthamiana . By comparing the glycosylation profiles of different hosts, we can select platforms that produce RBDs with the most beneficial N -glycan structures for different applications.
- Published
- 2024
- Full Text
- View/download PDF